2m 2m 2m 2m 2m 2m 2m
Myriad Genetics (MYGN)
NASDAQ
$4.63+$0.13 (+2.89%)
Price as of Jun 23, 2026 5:18 PM EDT- $425.0MMarket Cap
- -7.41%1-Year Change
- Diagnostics & ResearchIndustry
Myriad Genetics (MYGN)
$4.63+$0.13 (+2.89%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 824.5M -1.56% | 837.6M +11.21% | 753.2M +11.03% | 678.4M -1.77% | |
Cost of Revenue | 247.9M -1.70% | 252.2M +6.77% | 236.2M +16.93% | 202.0M +2.23% | |
Gross Profit | 576.6M -1.50% | 585.4M +13.23% | 517.0M +8.52% | 476.4M -3.37% | |
Sales and Marketing Expense | 280.8M -1.16% | 284.1M -50.41% | 572.9M +11.31% | 514.7M -4.30% | |
Research and Development Expense | -106.8M -5.82% | -113.4M +27.85% | -88.7M +3.86% | -85.4M +4.27% | |
Depreciation and Amortization Expense | 53.7M -12.25% | 61.2M -1.13% | 61.9M +17.46% | 52.7M -16.08% | |
Total Operating Expenses | 963.8M +35.96% | 708.9M -29.85% | 1.0B +23.39% | 819.0M -7.05% | |
Operating Profit | -387.2M +213.52% | -123.5M -52.02% | -257.4M +83.07% | -140.6M -26.19% | |
Interest Income | 1.8M +5.88% | 1.7M -32.00% | 2.5M -3.85% | 2.6M +271.43% | |
Interest Expense | N/A N/A | N/A N/A | -2.9M -9.37% | -3.2M -51.52% | |
Interest Income and Expense and Net | 1.8M +5.88% | 1.7M +525.00% | -400,000 -33.33% | -600,000 -89.83% | |
Total Nonoperating Income and Expense | -7.9M N/A | 0 +100.00% | -4.8M N/A | 0 -100.00% | |
Income before Taxes | -395.1M +219.92% | -123.5M -52.90% | -262.2M +86.49% | -140.6M +146.23% | |
Income Taxes | -29.2M -868.42% | 3.8M +245.45% | 1.1M +103.85% | -28.6M -4.35% | |
Extraordinary Items | 319.4M +464.31% | 56.6M +234.91% | 16.9M 0.00% | 16.9M N/A | |
Net Income | -365.9M +187.43% | -127.3M -51.65% | -263.3M +135.09% | -112.0M +311.76% | |
Net Income from Continuing Operations Applicable to Common | -395.1M +219.92% | -123.5M -52.90% | -262.2M +86.49% | -140.6M +146.23% | |
Basic EPS and Net Income | -3.95 +180.14% | -1.41 -55.66% | -3.18 +128.78% | -1.39 +297.14% | |
Diluted EPS and Net Income | -3.95 +180.14% | -1.41 -55.66% | -3.18 +128.78% | -1.39 +297.14% | |
Basic Weighted Average Shares | 92.6M +2.21% | 90.6M +9.42% | 82.8M +2.73% | 80.6M +3.33% | |
Diluted Weighted Average Shares | 92.6M +2.21% | 90.6M +9.42% | 82.8M +2.73% | 80.6M +3.33% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 149.6M +46.09% | 102.4M -22.48% | 132.1M +132.16% | 56.9M -77.98% | |
Short-Term Investments | N/A N/A | 0 -100.00% | 8.8M -84.83% | 58.0M -28.75% | |
Cash and Cash Equivalents and Short-Term Investments | 149.6M +46.09% | 102.4M -27.32% | 140.9M +22.63% | 114.9M -66.19% | |
Total Current Assets | 332.6M +11.61% | 298.0M -4.97% | 313.6M +14.20% | 274.6M -43.36% | |
Accumulated Depreciation | 87.9M -19.80% | 109.6M -8.59% | 119.9M +9.80% | 109.2M +2.15% | |
Property and Plant and Equipment and Net | 114.0M -2.90% | 117.4M -1.34% | 119.0M +42.69% | 83.4M +91.72% | |
Total Long-Term Assets | 5.6M -34.12% | 8.5M -44.81% | 15.4M -0.65% | 15.5M +86.75% | |
Total Assets | 706.6M -31.24% | 1.0B -10.37% | 1.1B -4.35% | 1.2B -9.24% | |
Income Taxes Payable | 5.7M +11.76% | 5.1M +10.87% | 4.6M +31.43% | 3.5M -90.22% | |
Total Short-Term Debt | N/A N/A | N/A N/A | 40.7M N/A | N/A N/A | |
Total Current Liabilities | 133.8M -18.46% | 164.1M +5.26% | 155.9M +13.63% | 137.2M -32.84% | |
Total Long-Term Debt | 119.9M +202.78% | 39.6M +2.86% | 38.5M N/A | 0 N/A | |
Total Long-Term Liabilities | 1.7M -22.73% | 2.2M -94.67% | 41.3M +184.83% | 14.5M +158.93% | |
Total Liabilities | 338.6M +3.71% | 326.5M -10.13% | 363.3M +16.11% | 312.9M -11.33% | |
Retained Earnings | -1.1B +48.35% | -756.8M +20.22% | -629.5M +71.90% | -366.2M +44.06% | |
Total Stockholders Equity | 368.0M -47.51% | 701.1M -10.48% | 783.2M -11.58% | 885.8M -8.47% | |
Total Shares Outstanding | 93.5M +2.41% | 91.3M +1.56% | 89.9M +10.71% | 81.2M +1.50% | |
Cash Flow | |||||
Cash from Operating Activities | 1.8M +120.69% | -8.7M -92.16% | -110.9M +4.33% | -106.3M -684.07% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | 45.3M +151.67% | |
Cash from Investing Activities | -27.4M +130.25% | -11.9M -137.30% | 31.9M +141.16% | -77.5M -128.24% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 64.2M +967.57% | -7.4M -104.84% | 152.9M +2,011.25% | -8.0M -94.69% | |
Financials Ratio | |||||
Gross Margin | 69.93% +0.06% | 69.89% +1.82% | 68.64% -2.26% | 70.22% -1.63% | |
Operating Margin | -46.96% +218.50% | -14.74% -56.85% | -34.17% +64.89% | -20.73% -24.87% | |
Return on Assets | -42.20% +260.34% | -11.71% -47.85% | -22.45% +152.55% | -8.89% +347.73% | |
Return on Equity | -68.45% +299.06% | -17.15% -45.64% | -31.55% +161.09% | -12.08% +310.71% | |
Revenue Growth | -1.56% -113.96% | 11.21% +1.63% | 11.03% +724.13% | -1.77% -101.36% | |
Current Ratio | 2.49 +36.88% | 1.82 -9.72% | 2.01 +0.50% | 2.00 -15.66% | |
Cash Ratio | 1.12 +79.18% | 0.62 -26.35% | 0.85 +104.32% | 0.41 -67.21% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | 0.10 N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | 0.07 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow